Serum Brain-Derived Neurotrophic Factor (BDNF): The severity and symptomatic dimensions of depression

Psychiatria Danubina

Volumn 23, Issue 4, 2011, Pages 363-369

  Jevtović, Saša ^a   Karlović, Dalibor ^b   Mihaljević Peleš, Alma ^a   Šérić, Vesna ^b   Vrkić, Nada ^b   Jakšić, Nenad ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

BDNF; Biological marker; Brain derived neurotrophic factor; Depression; MDD

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FACTORIAL ANALYSIS; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; SYMPTOMATOLOGY;

ADULT; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PSYCHOMETRICS;

EID: 82155191318     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, et al.: Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prag Neuropsychopharmacol Biol Psychiatry 2006; 30:1256-60. (Pubitemid 44216065)
2. Aydemir O, Deveci A, Taskin OE, Taneli F, Esen-Danaci A: Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1023-6. (Pubitemid 46810091)
3. Bagby RM, Ryder AG, Schuller DR, Marshall MB: The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight? Am J Psychiatry 2004; 161:2163-2177. (Pubitemid 39587278)
4. Barde YA, Edgar D, Thoenen H: Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1982; 1:549-53.
5. Benazzi F: Psychomotor changes in melancholic and atypical depression: 1976 unipolar bipolar-II II subtypes. Psychiatry Res. 2002; 112:211-20.
6. Brunoni AR, Lopes M, Fregni F: A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008; 11:1169-80.
7. Bus BAA, Molendijk ML, Penninx BJWH, Buitelaar JK, Kenis G, Prickaerts J, et al.: Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011; 36:228-39.
8. Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, Frati L, et al.: Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients. Am J Med Genet B Neuropsychiatr Genet. 2007; 144:574-7. (Pubitemid 46983172)
9. Cole JC, Motivala SJ, Dang J, Lucko A, Lang N, Levin MJ, Oxman MN, Irwin MR: Structural Validation of the Hamilton Depression Rating Scale. J Psychopath Behav Assess. 2004; 26:241-254. (Pubitemid 39422796)
10. Dell'Osso L, Del Debbio A, Veltri A, Bianchi C, Roncaglia I, Carlini M, et al.: Association between Brain-Derived Neurotrophic Factor Plasma Levels and Severity of the illness, Recurrence and Symptoms in Depressed Patients. Neuropsychobiology 2010; 62:207-12.
11. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, et al.: Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005; 51:234-8. (Pubitemid 40976406)
12. Gonul AS, Akedeniz F, Taneli F, Donat O, Eker C, Vahip S: Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci. 2005; 255:381-6. (Pubitemid 43029827)
13. Grassi-Oliveira R, Stein LM, Lopes RP, Teixeira AL, Bauer ME: Low plasma Brainderived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression - a preliminary report. Biol Psychiatry 2008; 64:281-285.
14. Gustafsson G, Lira CM, Johansson J, Wisen A, Wohlfart B, Ekman R, Westrin A: The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatry Res. 2009; 169:244-8.
15. Hallbook F, Ibanez CF, Persson H: Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 1991; 6:845-58.
16. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
17. Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, Sekine Y, et al.: Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1529-31. (Pubitemid 44634961)
18. Huang TL, Lee CT, Liu Yl: Serum brain-derived neurotrophic factor levels in patients with major depression:effect of antidepressants. J Psychiatric Res. 2007; 45:521-5.
19. Huang EJ, Reichardt LF: Neurotrophic: roles in neuronal development and junction. Ann Rev Neurosci. 2001; 24:677-736. (Pubitemid 32695243)
20. Ikeda Y, Yahata N, Ito I, Nagano M, Toyota T, Yoshikawa T, et al.: Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr Res. 2008; 101:58-66.
21. Jakovljević M: Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishful thinking or or an innovative strategy for superior management of depression? Psychiatria Danubina 2011; 23:2-9.
22. Jevtović S, Šagud M, Mihaljević-Peleš A: Hamiltonova ocjenska ljestvica za depresiju. U: Antidepresivi u kliničkoj praksi. Ur. A.Mihaljević-Peleš & M.Šagud. Medicinska naklada, Zagreb 2011; 63-66.
23. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G: Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Brain Res Mol Brain Res. 2005; 136:29-37.
24. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G: Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably result from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005; 57:1068-1072. (Pubitemid 40613035)
25. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum barin-derived neurotrophic facor levels in major depressed patients. Psychiatry Res. 2002; 109:143-8. (Pubitemid 34258493)
26. Kauer-Sant'Anna M, Tramontina J, Andreazza AC, Cereser K, da Costa S, Santin A et al.: Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord. 2007; 9:128-135.
27. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M et al.: Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 2011; 14:347-353.
28. Lee BH, Kim H, Park SH, Kim Yk: Decreased plasma BDNF level in depressive patients J Affect Disord. 2007; 101:239-44. (Pubitemid 46879923)
29. Lu B, Je HS: Neurotrophic regulation of the development and junction of the neuromuscular synapses. J Neurocytol. 2003; 32:931-41. (Pubitemid 39011270)
30. Lu B, Woo N: Trophic factors in synaptic plasticity and memory. Neuroscientist. 2006; 12:43-56.
31. Lommatzsch K, Zingler C, Schuff-Werner P: The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 2005; 26:115-123. (Pubitemid 39600596)
32. Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, Zanatto V, Kapczinski F, et al.: Decreased plasma brain derived neurotrophic factor levels in unmedical bipolar patients during manic episode. Biol Psychiatry 2007; 61:142-4. (Pubitemid 46072782)
33. Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME, Lindsay ME, et al.: Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990; 247:1446-51.
34. McAllister AK, Katz LC, Lo DC: Neurotrophic and synaptic plasticity. Annu Rev Neurosci. 1999; 22:295-318.
35. Mitoma M, Yoshimura R, Sugita A, Umene W, Hori H, Nakano H, Uead N, Nakamura J: Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as possible biological markers of mental stress? Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:679-85. (Pubitemid 351312365)
36. Molendijk ML, Bus BAA, Spinhoven P, Penninx BWJH, Kenis G, Prickaerts J, Oude Voshaar RC, Elzinga BM: Serum levels of brain-derived nerotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psych. 2011; 16:1088-1095.
37. Monteleone P, Serritella C, Martiadis V, Maj M: Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord. 2008; 10:95-100.
38. Nakazato M, Hashimoto K, Shimizu E, Kumakiri C, Koizumi H, Okamura N, et al.: Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 2003; 54:485-90. (Pubitemid 37289455)
39. Palomino A, Vallejo-Illarramendi A, González-Pinto A, Aldam A, González Gómez, C, Mosquera F, et al.: Decreased levels of plasma BDNF in first episode schizophrenia and bipolar disorder patients. Schizophr Res. 2006; 86:321-322. (Pubitemid 44234056)
40. Pang PT, Teng HK, Zaitsev E, Woo N, Sakata K, Zhen S et al.: Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004; 306:487-91. (Pubitemid 39372449)
41. Piccinni A, Marazziti D, Catena M, Domenici L, Del Debbio A, Bianchi C, et al.: Plasma and serum brainderived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord. 2008; 105:279-83. (Pubitemid 350245688)
42. Pintor L, Torres X, Navarro V, Martinez de Osaba MA, Matrai S, Gasto C: Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33:463-469.
43. Poo MM: Neurotrophic as synaptic modulators. Nat Rev Neurosci. 2001; 2:24-32.
44. Sen S, Duman R, Sanacora G: Seruma brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol Psychiatry 2008; 64:527-32.
45. Sheehan DV, Lecruiber Y, Sheehan KH et al.: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59:22-33. (Pubitemid 29001829)
46. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, et al.: Alterations of serum levels of brain--derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003;54:70-5. (Pubitemid 36776725)
47. Shvartzman P, Weiner Z, Vardy D, Friger M, Sherf M, Biderman A: Health services utilization by depressive patients identified by the MINI questionnaire in a primary care setting. Scand J Prim Health Care 2005; 23:18-25. (Pubitemid 41647159)
48. Sozeri-Varma G, Enli Y, Toker-Ugurlu T, Alacam H, Kalkan-Oguzhanoglu N: Decreased serum BDNF levels in major depressive patients. Neurology, Psychiatry and Brain Research. 2011; (In Press).
49. Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD: From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem. 2002; 9:224-37.
50. Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H: Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: Comparison between Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci. 2006; 256:402-6. (Pubitemid 44584054)
51. Yoshimura R, Mitoma M, Sugita A, Hori H, Okamoto T, Umene W, et al.: Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1034-7. (Pubitemid 46824019)